Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II tanezumab add-on to opioids for metastatic bone pain
2008-005181-31Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jan 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in bone metastases comparing Tanezumab + opioids with Placebo + opioids (2 arms). Primary endpoint: Primary efficacy endpoint. Started Jan 2009; status: completed.
02
Drugs
tanezumab
03
Conditions
bone metastases
Beyond the preview
Go deeper on 2008-005181-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005181-31.